I have posted this many times but if your interested in GW50156 read this
Invalid Link Removed
But, in 2007, GlaxoSmithKline decided to shelve 516. The company was about to embark on Phase III trials—the large, expensive, double-blind, placebo-controlled trials that are required for F.D.A...